FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051259403> ?p ?o ?g. }

• W2051259403 endingPage "282" @default.
• W2051259403 startingPage "277" @default.
• W2051259403 abstract "Asthma is a major cause of morbidity that disproportionately affects inner-city children. For children with persistent asthma, defined as having asthma symptoms 3 or more days per week or 3 or more nights per month, national guidelines recommend the use of daily antiinflammatory agents. Despite these recommendations, antiinflammatory agents remain underused, particularly in inner-city children with high asthma morbidity.The objectives of our study were to determine: 1) whether persistent asthma symptoms in inner-city children are related to acute care utilization and to the frequency of acute exacerbations; 2) whether children with persistent asthma are receiving recommended daily antiinflammatory agents; and 3) whether antiinflammatory medication use relates to sociodemographic factors, caretaker self-efficacy, the frequency of primary care visits, and/or measures of quality asthma care.A 64-item telephone survey was administered between July 1996 and June 1997 to 219 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center between January 1995 and February 1996. Persistent asthma symptoms were assessed by inquiring about the frequency of daily and nocturnal asthma symptoms over the last 4 weeks. Children's asthma severity was classified by applying the 1997 National Asthma Education and Prevention Program (NAEPP) Asthma Guidelines' severity classification scheme based on the frequency of asthma symptoms. Asthma morbidity was defined as the frequency of acute asthma exacerbations, emergency department visits and hospitalizations. Daily antiinflammatory medication use was compared by sociodemographic factors, caretaker self-efficacy, frequency of primary care visits, and measures of quality asthma home management.In this sample, quantifying persistent asthma symptoms and applying the NAEPP symptom criteria identified 17% of the children with mild intermittent asthma, 27% with mild persistent asthma and 56% with moderate to severe persistent asthma. There were no differences in the age of the children in the 3 groups (mean age: 6 years). Asthma morbidity, as measured by the number of asthma exacerbations in the last 6 months, was significantly higher in the children with moderate to severe persistent asthma compared with children with mild intermittent asthma (9.8 vs 3.5) or mild persistent asthma (9.8 vs 4.5). In addition, there were significantly more emergency department visits in the moderate to severe group than in the mild persistent (3.05 vs 1.69) or mild intermittent group (3.05 vs 1.76). Lastly, as asthma symptom frequency increased, there were trends toward more hospitalizations and more days hospitalized. Overall, 35% of the 219 families reported giving daily antiinflammatory medications to their child (mostly cromolyn sodium). Of the 181 children (83%) who met NAEPP symptom criteria for persistent asthma, only 39% were receiving daily antiinflammatory treatment. Of the children with symptoms of moderate to severe asthma, only 15% were receiving inhaled steroids in contrast to the guidelines' recommendations. Use of antiinflammatory agents was not related to caretaker sociodemographic factors or self-efficacy scores. Measures of quality asthma home management, which included use of mattress covers, written plans, and peak flow meters, correlated positively with use of antiinflammatory agents. Children whose families reported using daily antiinflammatory medications had more primary care visits in the last 6 months than those children not receiving antiinflammatory medications.Questioning parents about the frequency of their child's asthma symptoms is an important, inexpensive, and readily accessible bedside and office tool that may aid in the detection of persistent symptoms and help direct therapy. Our study suggests that classifying asthma severity by quantifying persistent asthma symptoms, as defined in the NAEPP Guidelines, is a clinically useful tool that relates to asthma morbidity. In our sample of previously hospitalized children with asthma, 83% met 1997 NAEPP symptom criteria for persistent asthma, and yet only 35% were receiving daily antiinflammatory agents. Use of antiinflammatory agents correlated positively with other indicators of quality asthma home management. Additional work is necessary to increase appropriate use of antiinflammatory agents in this population, and in particular, to increase inhaled steroid use for children with moderate or severe symptoms." @default.
• W2051259403 created "2016-06-24" @default.
• W2051259403 creator A5013296740 @default.
• W2051259403 creator A5066272714 @default.
• W2051259403 creator A5068863272 @default.
• W2051259403 date "2001-08-01" @default.
• W2051259403 modified "2023-09-23" @default.
• W2051259403 title "Asthma Symptoms, Morbidity, and Antiinflammatory Use in Inner-City Children" @default.
• W2051259403 cites W1930217380 @default.
• W2051259403 cites W1972304758 @default.
• W2051259403 cites W1973023029 @default.
• W2051259403 cites W1976490238 @default.
• W2051259403 cites W1986586541 @default.
• W2051259403 cites W1988691854 @default.
• W2051259403 cites W2003199954 @default.
• W2051259403 cites W2031880739 @default.
• W2051259403 cites W2072173344 @default.
• W2051259403 cites W2085977034 @default.
• W2051259403 cites W2098468589 @default.
• W2051259403 cites W2116341189 @default.
• W2051259403 cites W2139129119 @default.
• W2051259403 cites W4300519598 @default.
• W2051259403 doi "https://doi.org/10.1542/peds.108.2.277" @default.
• W2051259403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11483788" @default.
• W2051259403 hasPublicationYear "2001" @default.
• W2051259403 type Work @default.
• W2051259403 sameAs 2051259403 @default.
• W2051259403 citedByCount "106" @default.
• W2051259403 countsByYear W20512594032012 @default.
• W2051259403 countsByYear W20512594032013 @default.
• W2051259403 countsByYear W20512594032014 @default.
• W2051259403 countsByYear W20512594032015 @default.
• W2051259403 countsByYear W20512594032016 @default.
• W2051259403 countsByYear W20512594032017 @default.
• W2051259403 countsByYear W20512594032019 @default.
• W2051259403 countsByYear W20512594032021 @default.
• W2051259403 countsByYear W20512594032022 @default.
• W2051259403 countsByYear W20512594032023 @default.
• W2051259403 crossrefType "journal-article" @default.
• W2051259403 hasAuthorship W2051259403A5013296740 @default.
• W2051259403 hasAuthorship W2051259403A5066272714 @default.
• W2051259403 hasAuthorship W2051259403A5068863272 @default.
• W2051259403 hasConcept C118552586 @default.
• W2051259403 hasConcept C126322002 @default.
• W2051259403 hasConcept C159110408 @default.
• W2051259403 hasConcept C162324750 @default.
• W2051259403 hasConcept C187212893 @default.
• W2051259403 hasConcept C194828623 @default.
• W2051259403 hasConcept C26271046 @default.
• W2051259403 hasConcept C2776042228 @default.
• W2051259403 hasConcept C2779951463 @default.
• W2051259403 hasConcept C2780724011 @default.
• W2051259403 hasConcept C2909082789 @default.
• W2051259403 hasConcept C2911164631 @default.
• W2051259403 hasConcept C2993877802 @default.
• W2051259403 hasConcept C71924100 @default.
• W2051259403 hasConceptScore W2051259403C118552586 @default.
• W2051259403 hasConceptScore W2051259403C126322002 @default.
• W2051259403 hasConceptScore W2051259403C159110408 @default.
• W2051259403 hasConceptScore W2051259403C162324750 @default.
• W2051259403 hasConceptScore W2051259403C187212893 @default.
• W2051259403 hasConceptScore W2051259403C194828623 @default.
• W2051259403 hasConceptScore W2051259403C26271046 @default.
• W2051259403 hasConceptScore W2051259403C2776042228 @default.
• W2051259403 hasConceptScore W2051259403C2779951463 @default.
• W2051259403 hasConceptScore W2051259403C2780724011 @default.
• W2051259403 hasConceptScore W2051259403C2909082789 @default.
• W2051259403 hasConceptScore W2051259403C2911164631 @default.
• W2051259403 hasConceptScore W2051259403C2993877802 @default.
• W2051259403 hasConceptScore W2051259403C71924100 @default.
• W2051259403 hasIssue "2" @default.
• W2051259403 hasLocation W20512594031 @default.
• W2051259403 hasLocation W20512594032 @default.
• W2051259403 hasOpenAccess W2051259403 @default.
• W2051259403 hasPrimaryLocation W20512594031 @default.
• W2051259403 hasRelatedWork W1134074977 @default.
• W2051259403 hasRelatedWork W158866585 @default.
• W2051259403 hasRelatedWork W1948460711 @default.
• W2051259403 hasRelatedWork W2020148527 @default.
• W2051259403 hasRelatedWork W2036652080 @default.
• W2051259403 hasRelatedWork W2051259403 @default.
• W2051259403 hasRelatedWork W2098935330 @default.
• W2051259403 hasRelatedWork W2161110895 @default.
• W2051259403 hasRelatedWork W2618121052 @default.
• W2051259403 hasRelatedWork W2792026763 @default.
• W2051259403 hasVolume "108" @default.
• W2051259403 isParatext "false" @default.
• W2051259403 isRetracted "false" @default.
• W2051259403 magId "2051259403" @default.
• W2051259403 workType "article" @default.